2.1-header-iStock-1131359120

Bagaimana Cara Mendiagnosis Osteoartritis?

Jika Anda mulai merasakan gejala osteoartritis, jangan ditunda-tunda lagi. Anda harus segera ke dokter dan mendapatkan diagnosis yang tepat.16

Jika Anda didiagnosis osteoartritis, memilih pengobatan terbaik bergantung pada status kesehatan Anda, obat-obatan lain yang Anda gunakan, serta tingkat keparahan osteoartritis Anda, ringan, sedang, atau berat. Semakin cepat Anda dan dokter Anda bekerja sama, semakin cepat Anda dapat memulai rencana pengobatan yang efektif.

Pelajari lebih lanjut tentang penyebab, gejala  dan pilihan pengobatan osteoartritis.

Mendiagnosis osteoartritis biasanya membutuhkan empat langkah:

  • Riwayat kesehatan. Ini adalah alat bantu terbaik bagi dokter Anda dalam mendiagnosis osteoartritis. Konsultasikan dengan dokter Anda mengenai gejala, riwayat keluarga, dan kondisi kesehatan pada waktu lalu
  • Pemeriksaan fisik. Dokter Anda akan mengamati tanda-tanda khas osteoartritis, seperti pembengkakan atau nyeri tekan pada sendi, serta penurunan rentang gerak.
  • Sampel cairan sendi. Setelah memberikan bius lokal, dokter dapat mengambil sejumlah kecil cairan dari sendi Anda, yaitu cairan sinovial. Tes laboratorium terhadap cairan ini dapat membantu menegakkan diagnosis osteoartritis dan mengesampingkan kondisi lainnya.
  • Sinar-X atau MRI. Citra yang dihasilkan dapat memperlihatkan kerusakan di dalam sendi. Dokter Anda akan mengamati adanya kerusakan jaringan tulang rawan yang umumnya dialami dalam osteoartritis.

Summary of Indications for Use

DUROLANE (3 mL): Argentina, Australia,* Brazil, Chile, Colombia, EU,* India, New Zealand,* Russia, Switzerland,* Turkey,* United Arab Emirates: Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in Australia, EU and New Zealand for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.

Mexico: Symptomatic treatment of mild to moderate knee osteoarthritis.

Taiwan: Treatment of pain in OA of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. In addition, DUROLANE has been licensed for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, fingers and toes.

*DUROLANE is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure.

Full prescribing information can be found in product labeling.

Summary of risks: You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling.

Summary of Indications for Use for Curavisc: Curavisc (2 mL): EU, Brazil, Egypt, Malaysia: Pain and disturbed function in degenerative and traumatic disease of the joints. Curavisc can be used for large joints, e.g., knee, hip, or shoulder joint. Treatment course of 3- injections, up to 5- injections.

Summary of risks: You should not use CURAVISC if you have infections or skin disease at the injection site. CURAVSIC has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling and on the website at bioventus.com/curavisc.com.